Abstract
The number of children in the United States receiving psychiatric diagnoses and taking psychotropic medications rose significantly from the second half of the twentieth century through to today. Accompanying these increased rates of diagnosis and psychotropic medication use have come sometimes intense debates about whether the increases are appropriate, or whether healthy children are being mislabeled as sick and inappropriately given medications to alter their moods and behaviors. While these debates are in part highly technical, concerning questions in epidemiology and pharmacology, they are also infused with ethical questions about the appropriate goals of medicine, the nature of sickness and health, and the obligations we owe to children and families struggling to flourish. This chapter presents four inter-connected observations about the diagnosis and treatment of mood and behavioral disturbances in children that at least partially explain why this area generates concern and controversy, but that also point to important areas of agreement where progress can be made. These observations include that psychiatry can provide an important approach for understanding and responding to children’s mood and behavioral problems provided we remember that it also carries its own complexities and difficulties. Further, forces within and outside psychiatry can influence how diagnoses are made and how treatments are selected, including systemic forces that strongly favor medication over psychosocial treatments, with the result that children too often receive pharmacological treatment only, even when other interventions are supported by evidence, contribute towards long-term flourishing, and reflect families’ deepest value commitments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abela, J. R. Z., & Hankin, B. L. (Eds.). (2008). Handbook of depression in children and adolescents. New York: Guilford Press.
Adams, C. P., & Brantner, V. V. (2006). Estimating the cost of new drug development: Is it really $802 million? Health Affairs, 25(2), 420–428.
American Psychiatric Association (APA). (2013). Diagnostic and statistical manual of mental disorders, (DSM-5). Arlington: American Psychiatric Publishing.
Barkley, R. A. (2006). Attention-deficit hyperactivity disorder. In E. J. Mash & R. A. Barkley (Eds.), Child psychopathology (pp. 63–112). New York: Guilford Press.
Biederman, J. (2005). Attention-deficit/hyperactivity disorder: A selective overview. Biological Psychiatry, 57, 1215–1220.
Carey, W. B. (2011). Primary care physicians need a better understanding of temperamental variation. Hastings Center Report, 41(2), S14.
Carey, W. B., & McDevitt, S. C. (1995). Coping with children’s temperament: A guide for professionals. New York: Basic Books.
Centers for Disease Control and Prevention (CDC). (2013). Mental health surveillance among children – United States, 2005–2011. Morbidity and Mortality Weekly Report, 62(Suppl. 2), 1–35.
Coghill, D. (2004). Use of stimulants for attention deficit hyperactivity disorder. British Medical Journal, 329, 907–908.
Conrad, P. (2007). The medicalization of society: On the transformation of human conditions into treatable disorders. Baltimore: Johns Hopkins University Press.
Conrad, P., & Potter, D. (2000). From hyperactive children to ADHD adults: Observations on the expansion of medical categories. Social Problems, 47, 559–582.
Cooper, S., Valleley, R. J., Polaha, J., Begeny, J., & Evans, J. H. (2006). Running out of time: Physician management of behavioral health concerns in rural pediatric primary care. Pediatrics, 118(1), e132–e138.
Costello, E. J., Angold, A., Burns, B. J., Erkanli, A., Stangl, D. K., & Tweed, D. L. (1996). The Great Smoky Mountains Study of Youth: Functional impairment and serious emotional disturbance. Archives of General Psychiatry, 53(12), 1137.
Delate, T., Gelenberg, A. J., Simmons, V. A., & Motheral, B. R. (2004). Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Psychiatric Services, 55, 387–391.
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003). The price of innovation: New estimates of drug development costs. Journal of Health Economics, 22(2), 151–185.
Druss, B. G. (2011). The changing face of US mental health care. FOCUS: The Journal of Lifelong Learning in Psychiatry, 9(2), 221–222.
Fabiano, G. A., Pelham, W. E., Jr., Coles, E. K., Gnagy, E. M., Chronis-Tuscano, A., & O’Connor, B. C. (2009). A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clinical Psychology Review, 29(2), 129–140.
Foy, J. M., & Perrin, J. (2010). Enhancing pediatric mental health care: Strategies for preparing a community. Pediatrics, 125(Suppl. 3), S75–S86.
Frank, R. G., Conti, R. M., & Goldman, H. H. (2005). Mental health policy and psychotropic drugs. Milbank Quarterly, 83(2), 271–298.
Gagnon, M. A., & Lexchin, J. (2008). The cost of pushing pills: A new estimate of pharmaceutical promotion expenditures in the United States. PLoS Medicine, 5(1), e1.
Greely, H., Sahakian, B., Harris, J., Kessler, R. C., Gazzaniga, M., Campbell, P., & Farah, M. J. (2008). Towards responsible use of cognitive-enhancing drugs by the healthy. Nature, 456(7223), 702–705.
Habel, L. A., Schaefer, C. A., Levine, P., Bhat, A. K., & Elliott, G. (2005). Treatment with stimulants among youths in a large California health plan. Journal of Child and Adolescent Psychopharmacology, 15, 62–67.
Hinshaw, S. P. (1992). Externalizing behavior problems and academic underachievement in childhood and adolescence: Causal relationships and underlying mechanisms. Psychological Bulletin, 111, 127–155.
Horwitz, A. V., & Wakefield, J. C. (2007). The loss of sadness: How psychiatry transformed normal sorrow into depressive disorder. New York: Oxford University Press.
Jensen, P., Knapp, P., & Mrazek, D. (2006). Toward a new diagnostic system for child psychopathology: Moving beyond DSM. New York/London: The Guilford Press.
Kashani, J. H., Husain, A., Shekim, W. O., Hodges, K. K., Cytryn, L., & McKnew, D. H. (1981). Current perspectives on childhood depression: An overview. American Journal of Psychiatry, 138(2), 143–153.
Leibenluft, E., Charney, D. S., Towbin, K. E., Bhangoo, R. K., & Pine, D. S. (2003). Defining clinical phenotypes of juvenile mania. American Journal of Psychiatry, 160(3), 430–437.
March, J., & Vitiello, B. (2009). Clinical messages from the treatment for adolescents with depression study (TADS). American Journal of Psychiatry, 166(10), 1118–1123.
Martin, E. (2007). Bipolar expeditions: Mania and depression in American culture. Princeton: Princeton University Press.
McClellan, J. (2005). Commentary: Treatment guidelines for child and adolescent bipolar disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 44, 236–239.
Nature Editorial. (2010). A decade for psychiatric disorders. Nature, 463, 9.
Okie, S. (2005). Safety in numbers – Monitoring risk in approved drugs. New England Journal of Medicine, 352(12), 1173–1176.
Olfman, S. (Ed.). (2006). No child left different. Westport: Praeger Publishers.
Olfson, M., & Marcus, S. C. (2010). National trends in outpatient psychotherapy. American Journal of Psychiatry, 167(12), 1456–1463.
Olfson, M., Marcus, S. C., Weissman, M. M., & Jensen, P. S. (2002). National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 514–521.
Olfson, M., Crystal, S., Huang, C., & Gerhard, T. (2010). Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child & Adolescent Psychiatry, 49(1), 13–23.
Parens, E. (1998). Is better always good? In E. Parens (Ed.), Enhancing human traits: Ethical and social implications (pp. 1–28). Washington, DC: Georgetown University Press.
Parens, E. (Ed.). (2006). Surgically shaping children: Technology, ethics, and the pursuit of normality. Baltimore: Johns Hopkins University Press.
Parens, E., & Johnston, J. (2008). Understanding the agreements and controversies surrounding childhood psychopharmacology. Child and Adolescent Psychiatry and Mental Health, 2, 5.
Parens, E., & Johnston, J. (2009). Facts, values, and Attention-Deficit Hyperactivity Disorder (ADHD): An update on the controversies. Child and Adolescent Psychiatry and Mental Health, 3, 1.
Parens, E., & Johnston, J. (2010). Controversies concerning the diagnosis and treatment of bipolar disorder in children. Child and Adolescent Psychiatry and Mental Health, 4, 9.
Parens, E., & Johnston, J. (2011). Troubled children: Diagnosing, treating, and attending to context. Hastings Center Report, 41(2), S4–S31.
Parens, E., Johnston, J., & Carlson, G. A. (2010). Pediatric mental health care dysfunction disorder? The New England journal of medicine.
Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., & Jensen, P. S. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 44(6), 548–556.
Pelham, W. E., Foster, E. M., & Robb, J. A. (2007). The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. Journal of Pediatric Psychology, 32, 711–727.
Resko, S. (2011). Values talk exacerbates discrimination. Hastings Center Report, 41(2), S12.
Sadler, J. Z. (2007). The politics of psychiatry. Project Syndicate. http://www.project-syndicate.org/commentary/sadler2/English. Accessed 20 Jan 2014.
Sadler, J. Z., Jotterand, S. C. L. F., & Inrig, S. (2009). Can medicalization be good? Situating medicalization within bioethics. Theoretical Medicine and Bioethics, 30, 411–425.
Safer, D. J., Zito, J. M., & Fine, E. M. (1996). Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics, 98(6 Pt 1), 1084–1088.
Schlander, M. (2008). The NICE ADHD health technology assessment: A review and critique. Child and Adolescent Psychiatry and Mental Health, 2(1), 1.
Singh, I. (2004). Doing their jobs: Mothering with Ritalin in a culture of mother-blame. Social Science and Medicine, 59, 1193–1205.
Teich, J. L., & Buck, J. A. (2007). Mental health benefits in employer-sponsored health plans, 1997–2003. The Journal of Behavioral Health Services & Research, 34, 343–348.
Timimi, S., & Taylor, E. (2004). ADHD is best understood as a cultural context: For and against. British Journal of Psychiatry, 184, 8–9.
U.K. National Institute for Health and Clinical Excellence (NICE). (2008). Attention deficit hyperactivity disorder: Diagnosis and management of ADHD in children, young people and adults. http://www.nice.org.uk/guidance/index.jsp?action=byID&r=true&o=11632. Accessed 20 Jan 2014.
Wakefield, J. C. (2013). The DSM-5 debate over the bereavement exclusion: Psychiatric diagnosis and the future of empirically supported treatment. Clinical Psychology Review, 33, 825–845.
Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. The Lancet, 363(9418), 1341–1345.
Zito, J. M., Safer, D. J., dosReis, S., Gardner, J. F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. A. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatrics and Adolescent Medicine, 157, 17–25.
Zito, J. M., Derivan, A. T., Kratochvil, C. J., Safer, D. J., Fegert, J. M., & Greenhill, L. L. (2008). Child and adolescent psychiatry and mental health. Child and Adolescent Psychiatry and Mental Health, 2, 24.
Acknowledgments
This chapter is based on Erik Parens and Josephine Johnston (2008): www.capmh.com/content/2/1/5, and Erik Parens and Josephine Johnston (2011). This research was funded by grant U13 MH78722 of the National Institute of Mental Health and by Dr. Eve Hart Rice and Dr. Timothy D. Mattison.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Johnston, J., Parens, E. (2015). Neuroethical Issues in the Diagnosis and Treatment of Children with Mood and Behavioral Disturbances. In: Clausen, J., Levy, N. (eds) Handbook of Neuroethics. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4707-4_147
Download citation
DOI: https://doi.org/10.1007/978-94-007-4707-4_147
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-4706-7
Online ISBN: 978-94-007-4707-4
eBook Packages: Humanities, Social Sciences and Law